Skip to content
Clinical Trials – home
FinlandBack to Finland

Clinical trials in Jyvaskyla

35 clinical trials in Jyvaskyla, Finland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

FinlandOur site in FinlandKliinisetTutkimukset.fi(opens in a new tab)
Jyvaskyla at a glance
35
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

35 trials in Jyvaskyla

Open in trial search
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate
  • Sponsor:Dr. Falk Pharma GmbH
Countries:FinlandFinland
  • Participants:65+ years · Healthy volunteers
  • Substances:Recombinant Varicella Zoster Virus Glycoprotein E
  • Sponsor:GlaxoSmithKline Biologicals
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Iohexol
  • Sponsor:University Of Helsinki
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Dalteparin Sodium
  • Sponsor:Rigshospitalet
Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:HUS-yhtymae
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Vigabatrin
  • Sponsor:HUS-yhtymae

Embolism venous

Recruiting
Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:HUS-yhtymae
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Balcinrenone
  • Sponsor:AstraZeneca AB

Other cities in Finland

The busiest research cities in the country

All 28 cities in Finland

Clinical research in Jyvaskyla

What the registry says about research in the country

01 Cardiovascular Research

Innovative trials focusing on atherosclerotic cardiovascular disease and stroke prevention. Studies evaluate new treatments for heart failure and examine the effectiveness of medications for preventing major cardiac events.

  • Stroke Prevention in Atrial Fibrillation
  • Heart Failure Management
  • Coronary Artery Disease Treatment

Advanced research includes evaluation of novel anticoagulants and cardiac interventions for high-risk patients.

02 Immunology and Vaccines

Clinical studies examining meningococcal vaccines and influenza protection in various age groups. Research focuses on vaccine safety and immune response in different populations.

  • Meningococcal Prevention
  • High-dose Influenza Vaccines
  • Pediatric Vaccine Studies

Emphasis on developing effective immunization strategies for vulnerable populations.

03 Metabolic and Digestive Disorders

Comprehensive research into obesity management and gastrointestinal conditions. Studies include innovative treatments for celiac disease and weight management approaches.

  • Obesity Treatment
  • Celiac Disease Management
  • Gastrointestinal Health

Trials explore both medication-based and surgical interventions for various metabolic conditions.

04 Oncology Studies

Advanced research in prostate cancer treatment and renal cell carcinoma management. Studies evaluate new therapeutic approaches and post-surgical treatments.

  • Prostate Cancer Therapy
  • Renal Cell Carcinoma Treatment
  • Cancer Immunotherapy

Focus on developing targeted therapies and improving treatment outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).